Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)
China flag China · Delayed Price · Currency is CNY
11.60
-0.15 (-1.28%)
Nov 13, 2026, 3:04 PM CST

SHE:300452 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
1,003931.3871.93827.17694.08607.27
Other Revenue
11.4911.4910.6412.0910.449.43
1,015942.8882.57839.26704.53616.71
Revenue Growth
8.56%6.82%5.16%19.12%14.24%16.10%
Cost of Revenue
696.89643.94609.34573.93495.28438.93
Gross Profit
317.82298.86273.23265.33209.24177.78
Selling, General & Admin
72.667.8863.546051.1352.05
Research & Development
4642.2740.9541.9534.4326.8
Other Operating Expenses
0.24-2.51-1.6922.725.85
Operating Expenses
118.84107.64102.8103.9988.2384.7
Operating Income
198.98191.22170.43161.34121.0193.08
Interest Expense
-13.82-13.14-12.73-4.3-1.21-1.2
Interest & Investment Income
20.9814.8920.1811.849.056.93
Currency Exchange Gain (Loss)
-1.06-1.061.880.372.56-0.28
Other Non Operating Income (Expenses)
-6.1-0.47-0.42-0.41-0.38-0.39
EBT Excluding Unusual Items
198.97191.42179.34168.84131.0298.14
Impairment of Goodwill
---39.13---6.13
Gain (Loss) on Sale of Investments
-8.155.92-3.138.51-2.621.74
Gain (Loss) on Sale of Assets
-2.02-0.960.11-0.01-0.27-2.96
Asset Writedown
-0.14-0.14-0-1.02-0.01-
Other Unusual Items
2.742.455.179.58.295.89
Pretax Income
191.4198.68142.36185.82136.496.68
Income Tax Expense
24.8825.5121.8321.25.4711.14
Earnings From Continuing Operations
166.52173.17120.52164.62130.9385.54
Minority Interest in Earnings
2.853.38-1.1-3.09-0.233.72
Net Income
169.37176.55119.42161.54130.7189.25
Net Income to Common
169.37176.55119.42161.54130.7189.25
Net Income Growth
30.72%47.84%-26.07%23.58%46.45%-4.99%
Shares Outstanding (Basic)
238235234234233235
Shares Outstanding (Diluted)
242242234241233235
Shares Change
1.49%3.28%-2.88%3.29%-0.63%1.93%
EPS (Basic)
0.710.750.510.690.560.38
EPS (Diluted)
0.700.730.510.670.560.38
EPS Growth
28.80%43.14%-23.88%19.64%47.37%-6.79%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
164.86151.2690.3977.3865.572.35
Free Cash Flow Per Share
0.680.630.390.320.280.31
Dividend Per Share
0.3000.3000.3000.2500.2500.231
Dividend Growth
0%0%20.00%0%8.32%20.02%
Gross Margin
31.32%31.70%30.96%31.61%29.70%28.83%
Operating Margin
19.61%20.28%19.31%19.22%17.18%15.09%
Profit Margin
16.69%18.73%13.53%19.25%18.55%14.47%
Free Cash Flow Margin
16.25%16.04%10.24%9.22%9.30%11.73%
EBITDA
254.27244.56221.18200.12157.07127.77
EBITDA Margin
25.06%25.94%25.06%23.84%22.30%20.72%
D&A For EBITDA
55.2953.3450.7538.7836.0634.68
EBIT
198.98191.22170.43161.34121.0193.08
EBIT Margin
19.61%20.28%19.31%19.22%17.18%15.09%
Effective Tax Rate
13.00%12.84%15.33%11.41%4.01%11.53%
Revenue as Reported
1,015942.8882.57839.26704.53616.71
Advertising Expenses
-0.80.970.860.640.44